We are to email two newsletters a year to members in future. David Casley, Prospect Publicity 07860 369064; Email  prospect.bristol@gmail.com

News

GPs back screening

94pc of GPs would support launch of a national PCa screening programme for high-risk men. See

Ultra-fast MRI

Experienced US radiologists can now identify areas that are suspicious for clinically significant PCa. This helps avoid unnecessary biopsies, but if a biopsy is indicated, the area can be targeted with fewer needles. Only snag is it takes 30 minutes. See

Erectile function hope

A more precise form of PCa surgery nearly doubles the chances of men retaining erectile function  compared with standard surgery, according to the first comprehensive trial of the procedure.

Learn from others

This post contains hundreds of stories and experiences, helping patients learn from others who have been through it before. See here

PCa growth slowed

London scientists have shown that the drug NXP800, discovered at their institute, slowed the growth of PCa cells, including in cancer cells that are resistant to the hormone therapy enzalutamide (Jan ’25). See here

Starving cancer

American scientists have pioneered a groundbreaking approach to fighting cancer using engineered fat cells to starve it. More here

Radiotherapy talk

The recent talk by Zoe Walker on radiotherapy is available here

Ultrasound praised

A Glos man who was diagnosed with cancer twice in just over a year has praised a new non-invasive ultrasound treatment which saved him after enduring the “hell” of chemotherapy. Stuart Emerson, 60, is advocating for early detection and HIFU rollouts, hoping to spare others from invasive treatments and long recovery periods. More here

Cases rise

A new report shows there was an increase in new PCa cases in 2023 in England (9% more compared with 2022 and 25% more compared with 2019). And in 2022 in Wales (26% more in 2022
compared with 2021). More here

Diagnosis improves

The proportion of patients diagnosed with cancer at an early stage has risen to its highest level on record, NHS figures in England show. Data for the 13 most common cancers show 58.7% of those diagnosed between September 2023 and August 2024 were identified at stages one and two, which increases the chances of survival (Jan ’25). More here